Regulatory Recap: Generic Medicines Work-Sharing Initiative Outlines Foreign Comparator Acceptability
FDA and EMA’s New Guidances, Swissmedic Approval Timelines, And Biosimilars In Singapore
Generics Bulletin reviews the latest regulatory events across the world.
